Literature DB >> 16340402

Epidemiology of the diabetic heart.

Dimitrios N Tziakas1, Georgios K Chalikias, Juan Carlos Kaski.   

Abstract

Diabetes mellitus is a worldwide epidemic. Cardiovascular disease remains the major cause of morbidity and mortality in people with diabetes. Studies have suggested that increased risk of cardiovascular disease is not restricted to type II or type I diabetes mellitus, but extends to prediabetic stages such as impaired fasting glucose, impaired glucose tolerance, metabolic syndrome, and obesity. Insulin resistance, impaired fasting glucose, impaired glucose tolerance, and diabetes mellitus form a continuous sequence of risk for cardiovascular disease. Therefore, cardiovascular disease mortality and morbidity within the diabetes epidemic grow into vast proportions. Evidence also exists that diabetic patients have a high prevalence of heart failure or impaired diastolic and systolic cardiac function subsequent to the combination of coronary artery disease, hypertension, and diabetic cardiomyopathy. In view of the proportions of this new epidemic, prevention of diabetes and its prediabetic states is likely to be the most effective strategy to prevent serious cardiovascular events.

Entities:  

Mesh:

Year:  2005        PMID: 16340402     DOI: 10.1097/00019501-200511001-00002

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  15 in total

1.  The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction a population-based study.

Authors:  Aaron M From; Christopher G Scott; Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

2.  Diastolic function in patients with heart failure with preserved ejection fraction and atrial fibrillation: impact of diabetes.

Authors:  Ruxandra-Nicoleta Horodinschi; Camelia Cristina Diaconu
Journal:  Am J Cardiovasc Dis       Date:  2021-10-25

3.  Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.

Authors:  Heng Zeng; Xiaochen He; Xuwei Hou; Lanfang Li; Jian-Xiong Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-20       Impact factor: 4.733

4.  Histological changes in the heart and the proximal aorta in experimental diabetic rats fed with Piper sarmentsoum.

Authors:  Zar Chi Thent; Teoh Seong Lin; Srijit Das; Zaiton Zakaria
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-04-02

Review 5.  [Diabetic cardiomyopathy--a type of coronary artery disease?].

Authors:  B Stratmann; I Stork; D Tschoepe
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

6.  Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging.

Authors:  Rajprasad Loganathan; Mehmet Bilgen; Baraa Al-Hafez; Mohammed D Alenezy; Irina V Smirnova
Journal:  Cardiovasc Diabetol       Date:  2006-04-04       Impact factor: 9.951

7.  Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice.

Authors:  Pei-Chun Chao; Cheng-Chin Hsu; Mei-Chin Yin
Journal:  Nutr Metab (Lond)       Date:  2009-08-14       Impact factor: 4.169

8.  Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker.

Authors:  Sara Nunes; Edna Soares; João Fernandes; Sofia Viana; Eugénia Carvalho; Frederico C Pereira; Flávio Reis
Journal:  Cardiovasc Diabetol       Date:  2013-03-07       Impact factor: 9.951

9.  Effect of streptozotocin-induced diabetes on left ventricular function in adult rats: an in vivo Pinhole Gated SPECT study.

Authors:  Bernard Cosyns; Steven Droogmans; Caroline Weytjens; Tony Lahoutte; Guy Van Camp; Danny Schoors; Philippe R Franken
Journal:  Cardiovasc Diabetol       Date:  2007-10-15       Impact factor: 9.951

Review 10.  A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications.

Authors:  Behzad Molavi; Negah Rassouli; Suveer Bagwe; Neda Rasouli
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.